These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1968740

  • 1. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 3. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 4. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 5. Alterations in plasma lipids consequent to endurance training and beta-blockade.
    Morton AR, Stanforth PR, Freund BJ, Joyner MJ, Jilka SM, Hartzell AA, Ewy GA, Wilmore JH.
    Med Sci Sports Exerc; 1989 Jun; 21(3):288-92. PubMed ID: 2567483
    [Abstract] [Full Text] [Related]

  • 6. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A, Tanskanen A, Temmerman J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T, Chin WP, Yoshida Y, Sun HT, Mitomi A, Ishibashi T, Tamura K, Imai S.
    Arch Int Pharmacodyn Ther; 1989 Aug; 302():145-57. PubMed ID: 2576891
    [Abstract] [Full Text] [Related]

  • 8. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H, Stradner F.
    Wien Med Wochenschr; 1986 Sep 15; 136(17):443-8. PubMed ID: 2879389
    [Abstract] [Full Text] [Related]

  • 9. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
    Harvengt C, Heller FR, Martiat P, Van Nieuwenhuyze Y.
    J Clin Pharmacol; 1987 Jul 15; 27(7):475-80. PubMed ID: 2888790
    [Abstract] [Full Text] [Related]

  • 10. Beta-blockade and plasma lipids.
    Lehtonen A.
    J Pharmacol; 1983 Jul 15; 14 Suppl 2():203-8. PubMed ID: 6138468
    [Abstract] [Full Text] [Related]

  • 11. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Jul 15; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

  • 12. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep 15; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 13. Effect of mepindolol on serum lipids.
    Martignoni A, Perani G, Finardi G, Mastropasqua E, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 15; 20(11):543-5. PubMed ID: 7174157
    [Abstract] [Full Text] [Related]

  • 14. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN, Brownlee WC, Large DM.
    Clin Sci (Lond); 1985 Dec 15; 69(6):713-9. PubMed ID: 2866062
    [Abstract] [Full Text] [Related]

  • 15. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec 15; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 16. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982 Dec 15; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR, Smith RD, Wolf PS, Russ TP.
    Res Commun Chem Pathol Pharmacol; 1986 Dec 15; 54(3):339-54. PubMed ID: 2879327
    [Abstract] [Full Text] [Related]

  • 18. [Lipoprotein metabolism and beta receptor blockers].
    Schauer UJ, Schauer I.
    Z Gesamte Inn Med; 1987 Apr 15; 42(8):201-5. PubMed ID: 2888241
    [Abstract] [Full Text] [Related]

  • 19. Metabolic changes during antihypertensive therapies.
    Krone W, Nägele H.
    J Hum Hypertens; 1989 Dec 15; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [Abstract] [Full Text] [Related]

  • 20. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM.
    Circulation; 1990 Sep 15; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.